Translational Development... (TDACU)

10.20

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

10.20

0.00%

After-hours: Apr 25, 2025, 04:00 PM EDT

Translational Development Acquisition Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	May 26, 2022
Net Income	-8.04K	-61.28K	-843	-843	-483.85K	-500	-602	-602	-1.7K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-680.65K	20.8K	22.00	22.00	1.51K	500.00	500.00	500.00	n/a
Other Non-Cash Items	-122.27K	n/a	821.00	821.00	482.34K	n/a	n/a	n/a	1.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-680.65K	20.8K	22.00	22.00	1.51K	500.00	500.00	500.00	n/a
Operating Cash Flow	-810.96K	-40.48K	n/a	n/a	n/a	n/a	-102	-102	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-174.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-174.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-663.46K	200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6.86M	-7.5K	35K	35K	n/a	n/a	n/a	n/a	62.5K
Financial Cash Flow	175.25M	192.5K	35K	35K	n/a	n/a	n/a	n/a	62.5K
Net Cash Flow	214.14K	152.02K	n/a	n/a	n/a	n/a	2.2K	n/a	62.5K
Free Cash Flow	-810.96K	-40.48K	n/a	n/a	n/a	n/a	-102	-102	n/a